New trial aims to solve the mystery of cancers with unknown origins

NCT ID NCT07366008

Not yet recruiting Knowledge-focused Sponsor: Haukeland University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is for people with Cancer of Unknown Primary (CUP), where doctors can't find where the cancer started. The goal is to use advanced genetic tests on tumor samples to identify the cancer's origin. This information may help doctors choose more effective treatments and improve survival. About 350 participants will provide biopsies, blood, and stool samples for analysis.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER OF UNKNOWN PRIMARY SITE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer of unknown primary site Neoplasms, Unknown Primary

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER OF UNKNOWN PRIMARY SITE

Contacts and locations

Locations

Akershus University Hospital

Oslo, Norway
Haukeland University Hospital

Bergen, 5021, Norway
Oslo University Hospital

Oslo, Norway
St Olavs Hospital

Trondheim, Norway
Stavanger University Hospital

Stavanger, Norway
University Hospital of North-Norway

Tromsø, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.